CT Healthcare Trust plc (CTHT)

Category Sector Equity Healthcare

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.

Sell

129.00p

Buy

131.20p

arrow-down-0.20p (-0.15%)

Discount/Premium

-10.10%

Estimated NAV

145.94p

Prices updated at 08 May 2026, 16:14 BST

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The investment objective of the Company is to provide shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company’s specific return objective shall be for its NAV per share (on a total return basis) to beat the total return of the MSCI World Health Care Index (in sterling) on a rolling 3 year period (the index total return including dividends reinvested on a net basis)

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Company name

Columbia Threadneedle Investments

Legal structure

Closed Ended Investment Company

Domicile

United Kingdom

Fiscal year end

30 Nov 2026

Launch date

02 Dec 2016

Lead manager

Kosta Kleyman

Lead manager start date

05 Mar 2026

Lead fund manager biography

Kosta Kleyman (PharmD) is a Doctorate of Pharmacy. Kosta has over a decade of healthcare experience, doctorate clinical training, and operational experience leading product launches in healthcare companies before leveraging that experience to invest in biotech/healthcare companies. He led cancer drug commercialization and clinical development for seven years at top-tier pharmaceutical and biotech companies before commencing his investment management career at a single-manager health-care-dedicated hedge fund prior to joining Columbia Threadneedle Investments in 2020.

Head office

290 Congress Street

Boston

United States

02110

800-225-2365

-

Company website

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.